EDR Tripeptide — Pineal Gland Bioregulator
A synthetic tripeptide (Glu-Asp-Arg) derived from the pineal gland, developed by the Khavinson Institute in St. Petersburg alongside Epithalon. While Epithalon targets telomerase and longevity pathways, Pinealon is specifically neuroprotective — promoting neuronal survival, reducing oxidative stress in the brain, and supporting cognitive function in aging. Part of the same Russian bioregulator peptide programme that produced Epithalon, with a comparable but distinct research dataset.
01 — Research Summary
Pinealon's evidence base mirrors Epithalon's in character — substantial Russian preclinical and animal data, limited Western peer review, and no completed human RCTs. The neuroprotective effects are consistent across the dataset.
Significantly improved neuronal survival under oxidative stress. Russian research demonstrated Pinealon significantly reduced neuronal apoptosis in oxidative stress models, with effects comparable to established neuroprotective agents — establishing the core neuroprotective mechanism.
Improved spatial learning and memory in aged animals. Animal studies in aged models showed Pinealon treatment improved performance on spatial learning tasks — suggesting cognitive preservation effects consistent with the neuroprotective mechanism.
Protected retinal ganglion cells from degeneration. Research documented Pinealon's neuroprotective effects extending to retinal ganglion cells — the neurons responsible for transmitting visual information — suggesting application in age-related macular degeneration and glaucoma research.
Enhanced longevity outcomes when combined with Epithalon. Russian research showed Pinealon and Epithalon have complementary mechanisms — Epithalon targeting systemic longevity and telomere maintenance, Pinealon specifically protecting neural tissue — with combination protocols showing enhanced outcomes versus either alone.
02 — Mechanism of Action
Pinealon's mechanism centres on neuroprotection through multiple converging pathways, all of which contribute to the preservation of neuronal function during aging.
Pinealon directly protects neurons from oxidative stress-induced apoptosis — the primary mechanism of age-related neuronal loss. The tripeptide appears to stabilise mitochondrial membrane potential in neurons under stress, preventing the cascade that leads to programmed cell death.
Research shows Pinealon upregulates endogenous antioxidant systems in neural tissue — particularly superoxide dismutase (SOD) activity — reducing reactive oxygen species accumulation that drives neurodegeneration.
Consistent with other Khavinson Institute bioregulators, Pinealon appears to modulate gene expression in neural cells — upregulating survival genes and downregulating pro-apoptotic pathways. This epigenetic-level action may explain the durable effects observed in animal studies.
As a peptide derived from pineal gland tissue, Pinealon has particular affinity for pineal gland cells — potentially supporting melatonin regulation and circadian function alongside its direct neuroprotective effects in the broader CNS.
Both are Russian bioregulator tripeptides from the Khavinson Institute, but they serve different functions. Epithalon targets telomerase activation and systemic longevity — it's a whole-body anti-aging compound. Pinealon is specifically neuroprotective — targeting brain and nervous system preservation. They're frequently stacked together in longevity protocols for complementary coverage, with Epithalon handling systemic aging and Pinealon protecting cognitive function.
03 — Dosing Protocols
Pinealon protocols mirror Epithalon — oral and injectable routes are both viable, with oral capsule being the most practical for most users.
| Protocol | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Oral capsule | 5–10 mg | Daily | 10–20 day cycles, 2–4x yearly | Most practical route. Oral bioavailability confirmed in Russian research. |
| Subcutaneous | 2–5 mg | Daily | 10 day cycles | Injectable form for improved bioavailability certainty. |
| Nasal spray | 1–2 mg | Daily | 10–20 days | Nasal route for direct CNS delivery — used in some Russian clinical protocols. |
| Stack with Epithalon | 5 mg Pinealon + standard Epithalon dose | Concurrent | Aligned cycles | Complementary longevity stack — brain protection plus systemic telomere support. |
Pinealon has a strong safety profile in all published research. No significant adverse effects documented. Main caveat is the predominantly Russian evidence base with limited Western validation. Human RCT data is absent. Long-term safety in humans is extrapolated from the broader Khavinson Institute bioregulator programme rather than Pinealon-specific human trials.
04 — Community Experiences
Pinealon is discussed primarily in longevity and biohacking communities — most often in the context of Russian bioregulator peptides alongside Epithalon. It has a smaller following than Epithalon given its more specific neuroprotective focus, but is increasingly mentioned in cognitive longevity protocols particularly among users already familiar with the Khavinson Institute research programme.
These are user-reported experiences from public forums. Not endorsed by Whats That Peptide and should not be interpreted as clinical evidence. Individual results vary. Always consult a healthcare professional.
"Running both together for 2 years now. Epithalon handles the systemic aging side, Pinealon for the brain specifically. Sleep is better, cognitive clarity maintained, no obvious side effects. The Russian data is unusual in its depth for this class..."
"More subtle than acute nootropics like Semax. This is maintenance not enhancement — you're protecting what you have rather than boosting above baseline. After 6 months I notice my baseline feels more consistent and stable..."
"The Khavinson Institute dataset is genuinely impressive in its consistency. These aren't random compounds — they're the output of a 40+ year research programme. Pinealon specifically for neuroprotection alongside Epithalon for longevity makes mechanistic sense..."
"Oral capsule works fine based on the Russian bioavailability data. Injectable is more certain but for Pinealon specifically the oral route seems adequate. Make sure you're getting actual EDR sequence — some vendors mislabel or substitute..."